Total Neoadjuvant Therapy (TNT) in Rectal Cancer

被引：0

作者：

Stephens, Sarah J. ^{[1
]}

Willett, Christopher G. ^{[1
]}

Palta, Manisha ^{[1
]}

Czito, Brian G. ^{[1
]}

机构：

[1] Duke Canc Ctr, Dept Radiat Oncol, Med Circle, POB 3085, Durham, NC 27710 USA

来源：

CURRENT COLORECTAL CANCER REPORTS | 2018年 / 14卷 / 06期

关键词：

Rectal cancer; Total neoadjuvant therapy; TNT; Total mesorectal excision; TME; Chemoradiation; Neoadjuvant; Organ preservation;

D O I：

10.1007/s11888-018-0415-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose of ReviewThis review summarizes the relevant literature on the use of total neoadjuvant therapy (TNT) for patients with locally advanced rectal cancer. It highlights the most notable literature published and briefly discusses future directions.Recent FindingsRecent randomized trials evaluating TNT show improved rates of pathologic complete response and patient treatment tolerance with this approach.SummaryThe rationale for TNT includes the poor patient tolerance of adjuvant chemotherapy and the persistent risk of distant disease in patients with locally advanced rectal cancer, despite improvements in local control. Randomized trials have focused on short-term pathologic endpoints. Ongoing phase 3 trials are evaluating long-term disease-related outcomes, allowing for a more thorough evaluation of this treatment paradigm. TNT may also facilitate organ preservation in appropriately selected patients.

引用

页码：199 / 206

页数：8

共 61 条

[1] No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT) [J].

Aldo, Sainato ;

Valentina, Cernusco Luna Nunzia ;

Vincenzo, Valentini ;

Antonino, De Paoli ;

Riccardo, Maurizi Enrici ;

Marco, Lupattelli ;

Cynthia, Aristei ;

Cristiana, Vidali ;

Monica, Conti ;

Alessandra, Galardi ;

Pietro, Ponticelli ;

Luisa, Friso Maria ;

Tiziana, Iannone ;

Mattia, Osti Falchetto ;

Bruno, Manfredi ;

Marianna, Coppola ;

Cinzia, Orlandini ;

Luca, Cionini .

RADIOTHERAPY AND ONCOLOGY, 2014, 113 (02) :223-229

[2] Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial [J].

Andre, Thierry ;

Boni, Corrado ;

Navarro, Matilde ;

Tabernero, Josep ;

Hickish, Tamas ;

Topham, Clare ;

Bonetti, Andrea ;

Clingan, Philip ;

Bridgewater, John ;

Rivera, Fernando ;

de Gramont, Aimery .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3109-3116

[3]

[Anonymous], 1985, NEW ENGL J MED, V312, P1465

[4]

[Anonymous], 2016, PROSP CHEM AL CHEM A

[5] Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study [J].

Borg, C. ;

Andre, T. ;

Mantion, G. ;

Boudghene, F. ;

Mornex, F. ;

Maingon, P. ;

Adenis, A. ;

Azria, D. ;

Piutti, M. ;

Morsli, O. ;

Bosset, J. F. .

ANNALS OF ONCOLOGY, 2014, 25 (11) :2205-2210

[6] Chemotherapy with preoperative radiotherapy in rectal cancer [J].

Bosset, Jean-Francois ;

Collette, Laurence ;

Calais, Gilles ;

Mineur, Laurent ;

Maingon, Philippe ;

Radosevic-Jelic, Ljiljana ;

Daban, Alain ;

Bardet, Etienne ;

Beny, Alexander ;

Ollier, Jean-Claude .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11) :1114-1123

[7] Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study [J].

Bosset, Jean-Francois ;

Calais, Gilles ;

Mineur, Laurent ;

Maingon, Philippe ;

Stojanovic-Rundic, Suzana ;

Bensadoun, Rene-Jean ;

Bardet, Etienne ;

Beny, Alexander ;

Ollier, Jean-Claude ;

Bolla, Michel ;

Marchal, Dominique ;

Van Laethem, Jean-Luc ;

Klein, Vincent ;

Giralt, Jordi ;

Clavere, Pierre ;

Glanzmann, Christoph ;

Cellier, Patrice ;

Collette, Laurence .

LANCET ONCOLOGY, 2014, 15 (02) :184-190

[8] Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial [J].

Breugom, A. J. ;

van Gijn, W. ;

Muller, E. W. ;

Berglund, A. ;

van den Broek, C. B. M. ;

Fokstuen, T. ;

Gelderblom, H. ;

Kapiteijn, E. ;

Leer, J. W. H. ;

Marijnen, C. A. M. ;

Martijn, H. ;

Kranenbarg, E. Meershoek-Klein ;

Nagtegaal, I. D. ;

Pahlman, L. ;

Punt, C. J. A. ;

Putter, H. ;

Roodvoets, A. G. H. ;

Rutten, H. J. T. ;

Steup, W. H. ;

Glimelius, B. ;

van de Velde, C. J. H. .

ANNALS OF ONCOLOGY, 2015, 26 (04) :696-701

[9] Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study [J].

Bujko, K. ;

Wyrwicz, L. ;

Rutkowski, A. ;

Malinowska, M. ;

Pietrzak, L. ;

Krynski, J. ;

Michalski, W. ;

Oledzki, J. ;

Kusnierz, J. ;

Zajac, L. ;

Bednarczyk, M. ;

Szczepkowski, M. ;

Tarnowski, W. ;

Kosakowska, E. ;

Zwolinski, J. ;

Winiarek, M. ;

Wisniowska, K. ;

Partycki, M. ;

Beczkowska, K. ;

Polkowski, W. ;

Stylinski, R. ;

Wierzbicki, R. ;

Bury, P. ;

Jankiewicz, M. ;

Paprota, K. ;

Lewicka, M. ;

Cisel, B. ;

Skorzewska, M. ;

Mielko, J. ;

Bebenek, M. ;

Maciejczyk, A. ;

Kapturkiewicz, B. ;

Dybko, A. ;

Hajac, L. ;

Wojnar, A. ;

Lesniak, T. ;

Zygulska, J. ;

Jantner, D. ;

Chudyba, E. ;

Zegarski, W. ;

Las-Jankowska, M. ;

Jankowski, M. ;

Kolodziejski, L. ;

Radkowski, A. ;

Zelazowska-Omiotek, U. ;

Czeremszynska, B. ;

Kepka, L. ;

Kolb-Sielecki, J. ;

Toczko, Z. ;

Fedorowicz, Z. .

ANNALS OF ONCOLOGY, 2016, 27 (05) :834-842

[10] Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial [J].

Chua, Yu Jo ;

Barbachano, Yolanda ;

Cunningham, David ;

Oates, Jacqui R. ;

Brown, Gina ;

Wotherspoon, Andrew ;

Tait, Diana ;

Massey, Alison ;

Tebbutt, Niall C. ;

Chau, Ian .

LANCET ONCOLOGY, 2010, 11 (03) :241-248

← 1 2 3 4 5 6 7 →